全球骨科手术再生医学产品市场：分析与预测 (2022-2028)

在 2021 年至 2027 年的预测期内，全球骨科再生医学产品市场规模预计将以 4% 左右的复合年增长率增长。

外科产品的技术不断进步和研发活动不断增加，预计将扩大全球市场。 另一个因素是世界上越来越多的肥胖者。 此外，创伤修復、骨科疼痛管理、关节重建、软骨和肌腱修復的增长以及关节炎和骨质疏鬆症等骨科问题发病率的上升预计将在未来几年推动市场。

本报告研究了全球骨科再生医学产品市场，并提供了市场概况、市场收入、按产品、应用、最终用户和地区划分的市场洞察力、市场动态、机会、公司概况等信息。

内容

第一章市场介绍

第 2 章调查方法和前提条件

• 整形外科再生医学产品市场研究进程
• 整形外科再生医学产品市场研究方法
• 受访者简介

第三章市场总结

第 4 章执行摘要

第 5 章 COVID-19 对全球骨科再生医学产品市场的影响

第 6 章全球骨科再生医学产品市场收入，2019-2027F

第 7 章市场洞察：按产品分类

• 同种异体移植
• 综合
• 基于细胞
• 粘度补充剂

第 8 章市场洞察：按应用

• 整形手术中的疼痛管理
• 创伤修復
• 软骨/肌腱修復
• 联合重建
• 其他

第 9 章市场洞察：最终用户

• 医院
• 门诊手术中心
• 其他

第 10 章市场洞察：按地区

• 北美市场
  • 美国
  • 加拿大
  • 其他北美地区
• 欧洲市场
  • 德国
  • 法国
  • 英国
  • 意大利
  • 西班牙
  • 其他欧洲
• 亚太市场
  • 中国
  • 日本
  • 印度
  • 澳大利亚
  • 亚太其他地区
• 其他区域市场

第 11 章骨科再生医学市场：市场动态

• 市场驱动力
• 市场问题
• 影响分析

第十二章骨科再生医学产品市场：机遇

第 13 章骨科再生医学市场：趋势

第 14 章法律和监管框架

第15章需求侧与供给侧分析

• 需求方分析
• 供应方分析

第 16 章价值链分析

第 17 章衝突场景

• 竞争格局
  • 波特的五力分析

第十八章公司简介

• Anika Therapeutics, Inc.
• Vericel Corporation
• Baxter
• Zimmer Biomet
• Stryker
• Smith & Nephew
• AlloSource
• Amniox Medical, Inc.
• VSY Biotechnology
• Aptissen S.A.

第19章 免责事项

The orthopedic regenerative surgical products market is expected to register a CAGR of approx. 4% over the period of 2021-2027. Regenerative orthopedics help treat discomfort and pain in the musculoskeletal system and improve the healing of orthopedic conditions, such as ligaments, tendon injuries, muscles, bones, knee meniscus, intervertebral discs life, and cartilage. These parts of the body have a relatively low capacity for self-healing. Regenerative orthopedic surgical products help these tissues heal faster. Orthopedic regenerative surgical products can help some patients avoid orthopedic surgery altogether. The global orthopedic regenerative surgical products market is anticipated to witness an uptick with the growing technological advancement and increased research and development activities for the surgical product. Some other factors which drive the market include the rise in the obese population across the globe. In 2020, according to Trust For America's Health, the U.S. adult obesity rate stands at 42.4 percent, the first time the national rate has passed the 40 percent mark, and further evidence of the country's obesity crisis. Owing to these glaring statistics the demand for orthopedic regenerative surgical products is anticipated to grow in the forthcoming years because obesity causes an alteration of bone-regulating hormones, increased oxidative stress and inflammation, and altered bone cell metabolism which damages the bone internally. Furthermore, the increase in the number of trauma repair, orthopedic pain management, joint reconstruction, and cartilage and tendon repair as well as the rising incidences of orthopedic problems such as arthritis and osteoporosis, are expected to drive the market for orthopedic regenerative surgical products market in the coming years.

Some of the major factors such as obesity coupled with the growing healthcare expenditure are propelling the growth of this market in the region. Moreover, an increase in road accident cases also propels the growth of the market. For instance, according to the studies in 2020, One of the factors causing bone fractures is Road Traffic Accidents (RTAs), which are the first leading cause of death among people aged 15-29 years. In 2019, the global number of new cases of fracture was estimated to be 178 million (95%), an increase of 33*4% since 1990. Furthermore, the increasing prevalence of joint reconstruction, growing health care expenditure, and awareness among patients and healthcare are significantly growing the orthopedic regenerative surgical products market.

Anika Therapeutics, Inc., Vericel Corporation, Baxter, Zimmer Biomet, Stryker, Smith & Nephew, AlloSource, Amniox Medical, Inc., VSY Biotechnology, Aptissen S.A. are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report:

"Amongst Product, the viscosupplements category accounted for the majority share in the market in 2020"

Based on product, the market is classified into allografts, synthetic, cell-based, and viscosupplements. Amongst these, the viscosupplement category accounted for a significant share of the market owing to the rising incidence of knee pain, osteoarthritis, and related symptoms and an increase in product availability driving the growth of this segment. Moreover, factors such as aging, obesity, excessive exercise, external injury, and genetic predisposition, further contribute to knee osteoarthritis, thus driving the market for orthopedic regenerative surgical products

"Among Applications, the joint reconstruction is expected to witness highest CAGR during the forecast period"

Based on application, the market is categorized into knee surgeries, hip surgeries, spine surgeries, and others. Among these, knee surgeries are expected to witness the highest CAGR during the forecast period. increasing surgical procedures, geriatric patients, and the incidence of trauma cases are likely to aid the segment's growth. In addition, increased adoption of regenerative solutions in joint reconstruction, and technological advancements also boost the segment of the market growth.

"Among End-Users, the Hospitals is expected to witness highest CAGR during the forecast period"

Based on end-users, the market is categorized into hospitals, ambulatory surgical centers, and others. Among these, the hospitals are expected to witness the highest CAGR during the forecast period. The hospital offers a wide range of treatment options in terms of pain management and orthopedic surgery. Furthermore, the factors contributing to the large share of the segment include a higher volume of orthopedic procedures performed in hospital settings.

"North America to witness significant growth during the forecast period"

For a better understanding of the market dynamics of the orthopedic regenerative surgical products market, a detailed analysis was conducted for different regions across the globe including North America (the U.S, Canada, and the Rest of North America), Europe (Germany, France, Spain, United Kingdom, Italy, and Rest of Europe), Asia-Pacific (China, India, Australia, Japan, and Rest of APAC), Rest of World has been conducted. North America constitutes a major market for the orthopedic regenerative surgical products market industry and generated revenue owing to the presence of well-established market players and technologically advanced healthcare facilities in the region.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts.

The report presents a quick review of overall industry performance at one glance.

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.

The study comprehensively covers the market across different segments.

Deep dive regional level analysis of the industry.

Customization Options:

Global orthopedic regenerative surgical products market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

• 1.1. Market Definitions
• 1.2. Limitation
• 1.3. Stake Holders
• 1.4. Currency used in Report

2 RESEARCH METHODOLOGY OR ASSUMPTION

• 2.1. Research Process of the Orthopedic Regenerative Surgical Products Market
• 2.2. Research Methodology of the Orthopedic Regenerative Surgical Products Market
• 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 GLOBAL ORTHOPEDIC REGENERATIVE SURGICAL PRODUCTS MARKET COVID-19 IMPACT

6 GLOBAL ORTHOPEDIC REGENERATIVE SURGICAL PRODUCTS MARKET REVENUE, 2019-2027F

7 MARKET INSIGHTS BY PRODUCT

• 7.1. Allografts
• 7.2. Synthetic
• 7.3. Cell-Based
• 7.4. Viscosupplements

8 MARKET INSIGHTS BY APPLICATION

• 8.1. Orthopedic Pain Management
• 8.2. Trauma Repair
• 8.3. Cartilage and Tendon Repair
• 8.4. Joint Reconstruction
• 8.5. Others

9 MARKET INSIGHTS BY END-USERS

• 9.1. Hospitals
• 9.2. Ambulatory Surgical Centers
• 9.3. Others

10 MARKET INSIGHTS BY REGION

• 10.1. North America Orthopedic Regenerative Surgical Products Market
  • 10.1.1. United States
  • 10.1.2. Canada
  • 10.1.3. Rest of North America
• 10.2. Europe Orthopedic Regenerative Surgical Products Market
  • 10.2.1. Germany
  • 10.2.2. France
  • 10.2.3. United Kingdom
  • 10.2.4. Italy
  • 10.2.5. Spain
  • 10.2.6. Rest of Europe
• 10.3. Asia Pacific Orthopedic Regenerative Surgical Products Market
  • 10.3.1. China
  • 10.3.2. Japan
  • 10.3.3. India
  • 10.3.4. Australia
  • 10.3.5. Rest of Asia Pacific
• 10.4. Rest of World Orthopedic Regenerative Surgical Products Market Rest of Asia Pacific

11 ORTHOPEDIC REGENERATIVE SURGICAL PRODUCTS MARKET DYNAMICS REST OF THE WORLD ORTHOPEDIC REGENERATIVE SURGICAL PRODUCTS MARKET

• 11.1. Market Drivers
• 11.2. Market Challenges
• 11.3. Impact Analysis

12 ORTHOPEDIC REGENERATIVE SURGICAL PRODUCTS MARKET OPPORTUNITIES

13 ORTHOPEDIC REGENERATIVE SURGICAL PRODUCTS MARKET TRENDS

14 LEGAL & REGULATORY FRAMEWORK

15 DEMAND AND SUPPLY SIDE ANALYSIS

• 15.1. Demand Side Analysis
• 15.2. Supply Side Analysis

16 VALUE CHAIN ANALYSIS

17 COMPETITIVE SCENARIO

• 17.1. Competitive Landscape
  • 17.1.1. Porter's Five Forces Analysis

18 COMPANY PROFILED

• 18.1. Anika Therapeutics, Inc.
• 18.2. Vericel Corporation
• 18.3. Baxter
• 18.4. Zimmer Biomet
• 18.5. Stryker
• 18.6. Smith & Nephew
• 18.7. AlloSource
• 18.8. Amniox Medical, Inc.
• 18.9. VSY Biotechnology
• 18.10. Aptissen S.A.

19 DISCLAIMER